Evaluation of ovarian reserve and the assisted reproductive technology (ART) cycles’ outcome as well as the relapse rate within one year after ART in women with multiple sclerosis: a case-control study-Reference-Cited by-同舟云学术

Evaluation of ovarian reserve and the assisted reproductive technology (ART) cycles’ outcome as well as the relapse rate within one year after ART in women with multiple sclerosis: a case-control study

Published:2024-08-13 Issue:1 Volume:17 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Arabipoor Arezoo^ORCID,Moini Ashraf^ORCID,Nabavi Seyed Massood,Mohiti Shima^ORCID,Mashayekhi Mehri,Zolfaghari Zahra

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13048-024-01483-4.pdf

Reference29 articles.

1. PA. GJaM. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol. 2011;234:7–18.

2. Bove R, Alwan S, Friedman JM, Hellwig K, Houtchens M, Koren G, et al. Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol. 2014;124(6):1157–68.

3. Houtchens MK, Edwards NC, Hayward B, Mahony MC, Phillips AL. Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: data from an administrative claims database. Multiple Scler Relat Disorders. 2020;46:102541.

4. Çil AP, Leventoğlu A, Sönmezer M, Soylukoç R, Oktay K. Assessment of ovarian reserve and doppler characteristics in patients with multiple sclerosis using immunomodulating drugs. J Turkish German Gynecol Association. 2009;10(4):213.

5. Thöne J, Kollar S, Nousome D, Ellrichmann G, Kleiter I, Gold R, et al. Serum anti-Müllerian hormone levels in reproductive-age women with relapsing–remitting multiple sclerosis. Multiple Scler J. 2015;21(1):41–7.